Plus Therapeutics (PSTV) Asset Utilization Ratio (2011 - 2026)

Plus Therapeutics (PSTV) has 14 years of Asset Utilization Ratio data on file, last reported at 0.29 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.29, down 48.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.29 (down 48.67% YoY), and the FY2025 annual result was 0.45, down 29.74% from the prior year.
• Asset Utilization Ratio fell to 0.29 in Q1 2026 per PSTV's latest filing, from 0.3 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.09 in Q1 2024 and troughed at 0.01 in Q4 2022.
• A 5-year average of 0.42 and a median of 0.36 in 2025 frame the typical range for Asset Utilization Ratio.
• On a YoY basis, Asset Utilization Ratio climbed as much as 7580.92% in 2023 and fell as far as 72.38% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then jumped by 7580.92% to 0.65 in 2023, then surged by 30.83% to 0.86 in 2024, then sank by 65.19% to 0.3 in 2025, then dropped by 4.01% to 0.29 in 2026.
• Business Quant data shows PSTV's Asset Utilization Ratio at 0.29 in Q1 2026, 0.3 in Q4 2025, and 0.36 in Q3 2025.